Cargando…

Identifying States of Collateral Sensitivity during the Evolution of Therapeutic Resistance in Ewing's Sarcoma

Advances in the treatment of Ewing's sarcoma (EWS) are desperately needed, particularly in the case of metastatic disease. A deeper understanding of collateral sensitivity, where the evolution of therapeutic resistance to one drug aligns with sensitivity to another drug, may improve our ability...

Descripción completa

Detalles Bibliográficos
Autores principales:	Scarborough, Jessica A., McClure, Erin, Anderson, Peter, Dhawan, Andrew, Durmaz, Arda, Lessnick, Stephen L., Hitomi, Masahiro, Scott, Jacob G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7334607/ https://www.ncbi.nlm.nih.gov/pubmed/32623338 http://dx.doi.org/10.1016/j.isci.2020.101293

Ejemplares similares

Network potential identifies therapeutic miRNA cocktails in Ewing sarcoma
por: Weaver, Davis T., et al.
Publicado: (2021)

Recent advances in targeted therapy for Ewing sarcoma
por: Pishas, Kathleen I., et al.
Publicado: (2016)

Cell Cycle Deregulation in Ewing's Sarcoma Pathogenesis
por: Kowalewski, Ashley A., et al.
Publicado: (2011)

Antibody detection of translocations in Ewing sarcoma
por: Luo, Wen, et al.
Publicado: (2012)

Microsatellites with Macro-Influence in Ewing Sarcoma
por: Monument, Michael J., et al.
Publicado: (2012)

Investigating the role of LSD2 as an epigenetic regulator in Ewing sarcoma
por: Patel, Priyal O., et al.
Publicado: (2019)

Is There a Predisposition Gene for Ewing's Sarcoma?
por: Randall, R. L., et al.
Publicado: (2010)

Increased risk for other cancers in individuals with Ewing sarcoma and their relatives
por: Abbott, Diana, et al.
Publicado: (2019)

Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation
por: Pishas, Kathleen I., et al.
Publicado: (2018)

Signature-Based Small Molecule Screening Identifies Cytosine Arabinoside as an EWS/FLI Modulator in Ewing Sarcoma
por: Stegmaier, Kimberly, et al.
Publicado: (2007)

Mechanism and relevance of EWS/FLI-mediated transcriptional repression in Ewing sarcoma
por: Sankar, Savita, et al.
Publicado: (2012)

Therapeutic opportunities in Ewing sarcoma: EWS-FLI inhibition via LSD1 targeting
por: Theisen, Emily R., et al.
Publicado: (2016)

Antibiotic collateral sensitivity is contingent on the repeatability of evolution
por: Nichol, Daniel, et al.
Publicado: (2019)

Targeting Glutathione S-transferase M4 in Ewing sarcoma
por: Zhuo, Rupeng, et al.
Publicado: (2014)

BCL11B Is Up-Regulated by EWS/FLI and Contributes to the Transformed Phenotype in Ewing Sarcoma
por: Wiles, Elizabeth T., et al.
Publicado: (2013)

Identification of two types of GGAA-microsatellites and their roles in EWS/FLI binding and gene regulation in Ewing sarcoma
por: Johnson, Kirsten M., et al.
Publicado: (2017)

Targeted Therapy of Ewing's Sarcoma
por: Subbiah, Vivek, et al.
Publicado: (2011)

EWS/FLI Mediates Transcriptional Repression via NKX2.2 during Oncogenic Transformation in Ewing's Sarcoma
por: Owen, Leah A., et al.
Publicado: (2008)

EWS/FLI mediated reprogramming of 3D chromatin promotes an altered transcriptional state in Ewing sarcoma
por: Showpnil, Iftekhar A, et al.
Publicado: (2022)

EWS/FLI utilizes NKX2-2 to repress mesenchymal features of Ewing sarcoma
por: Fadul, John, et al.
Publicado: (2015)

Role of immunotherapy in Ewing sarcoma
por: Morales, Erin, et al.
Publicado: (2020)

Cutaneous Ewing Sarcoma and Ewing Sarcoma of the Bone: Distinct Diseases
por: Tavakkoli, Montreh, et al.
Publicado: (2018)

Emerging novel agents for patients with advanced Ewing sarcoma: a report from the Children’s Oncology Group (COG) New Agents for Ewing Sarcoma Task Force
por: Bailey, Kelly, et al.
Publicado: (2019)

Gastric Ewing Sarcoma identified on a Meckel's scan
por: Nissim, Lavi, et al.
Publicado: (2020)

609. Differing Genotypic Contexts Between E. coli and A. baumannii Modulate the Role of blaADC-7 in the Development of Antibiotic Collateral Sensitivity
por: McClure, Erin, et al.
Publicado: (2019)

Identification of a Novel FUS/ETV4 Fusion and Comparative Analysis with Other Ewing Sarcoma Fusion Proteins
por: Boone, Megann A., et al.
Publicado: (2021)

Survey of Paediatric Oncologists and Pathologists regarding Their Views and Experiences with Variant Translocations in Ewing and Ewing-Like Sarcoma: A Report of the Children's Oncology Group
por: Kinnaman, Michael D., et al.
Publicado: (2020)

Ewing's sarcoma of zygoma
por: Deshingkar, SA, et al.
Publicado: (2009)

Ewing's sarcoma of the mandible
por: Rao, B. H. Sripathi, et al.
Publicado: (2011)

Chemotherapy in Ewing’s sarcoma
por: Jain, Sandeep, et al.
Publicado: (2010)

The Biology of Ewing Sarcoma
por: Ross, Keir A., et al.
Publicado: (2013)

Ewing's Sarcoma of the Finger
por: Gökalp, Mehmet Ata, et al.
Publicado: (2014)

Ewing's Sarcoma of the Calcaneum
por: Sherif, P Ajmal, et al.
Publicado: (2017)

Paratesticular Ewing's sarcoma
por: Koshevarova, Victoria, et al.
Publicado: (2023)

Biomarkers in Ewing Sarcoma: The Promise and Challenge of Personalized Medicine. A Report from the Children’s Oncology Group
por: Shukla, Neerav, et al.
Publicado: (2013)

Mitochondrial Dysfunction Is a Driver of SP-2509 Drug Resistance in Ewing Sarcoma
por: Tokarsky, E. John, et al.
Publicado: (2022)

The PARP inhibitor olaparib enhances the sensitivity of Ewing sarcoma to trabectedin
por: Ordóñez, José Luis, et al.
Publicado: (2015)

Ewing Sarcoma and Ewing-Like Sarcoma and the Role of NKX2.2 Immunoreactivity
por: Ullah, Asad, et al.
Publicado: (2021)

A Decade in Banking Ewing Sarcoma: A Report from the Children’s Oncology Group
por: Borinstein, Scott C., et al.
Publicado: (2013)

Protein phosphatase 1 regulatory subunit 1A regulates cell cycle progression in Ewing sarcoma
por: Luo, Wen, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_diatonpoib4mrdpml7n8hl6mgj